These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2833479)

  • 1. Adrenocorticotropin-containing neoplastic cells in a pars intermedia adenoma in a horse.
    Horvath CJ; Ames TR; Metz AL; Larson VL
    J Am Vet Med Assoc; 1988 Feb; 192(3):367-71. PubMed ID: 2833479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in thoroughbreds.
    Okada T; Shimomuro T; Oikawa M; Nambo Y; Kiso Y; Morikawa Y; Liptrap RM; Yamashiro S; Little PB; Sasaki F
    Am J Vet Res; 1997 Aug; 58(8):920-4. PubMed ID: 9256982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992).
    van der Kolk JH; Kalsbeek HC; van Garderen E; Wensing T; Breukink HJ
    Vet Rec; 1993 Dec; 133(24):594-7. PubMed ID: 8116170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pituitary adrenocorticotropin-dependent Cushing's syndrome in the horse.
    Moore JN; Steiss J; Nicholson WE; Orth DN
    Endocrinology; 1979 Mar; 104(3):576-82. PubMed ID: 220013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A horse with Cushing's disease].
    van der Kolk JH; Klein WR; van der Putten SW; Mol JA
    Tijdschr Diergeneeskd; 1991 Jul; 116(13):670-5. PubMed ID: 1650504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary-dependent hyperadrenocorticism in a cat.
    Peterson ME; Steele P
    J Am Vet Med Assoc; 1986 Sep; 189(6):680-3. PubMed ID: 3019973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of equine pituitary pars intermedia adenoma.
    van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
    Domest Anim Endocrinol; 1995 Jan; 12(1):35-9. PubMed ID: 7621678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma.
    van der Kolk JH; Heinrichs M; van Amerongen JD; Stooker RC; in de Wal LJ; van den Ingh TS
    Am J Vet Res; 2004 Dec; 65(12):1701-7. PubMed ID: 15631037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma.
    Eiler H; Oliver JW; Andrews FM; Fecteau KA; Green EM; McCracken M
    J Am Vet Med Assoc; 1997 Jul; 211(1):79-81. PubMed ID: 9215417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic testing for pituitary pars intermedia dysfunction in horses.
    Dybdal NO; Hargreaves KM; Madigan JE; Gribble DH; Kennedy PC; Stabenfeldt GH
    J Am Vet Med Assoc; 1994 Feb; 204(4):627-32. PubMed ID: 8163420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical symptoms of and diagnostic possibilities for hypophyseal adenoma in horses].
    Feige K; Eser MW; Geissbühler U; Balestra E; Metzler K
    Schweiz Arch Tierheilkd; 2000 Feb; 142(2):49-54. PubMed ID: 10697998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid metabolism in horses with hyperadrenocorticism.
    van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
    J Am Vet Med Assoc; 1995 Apr; 206(7):1010-2. PubMed ID: 7768707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenomas of the pars intermedia associated with hyperglycemia and glycosuria in two horses.
    Loeb WF; Capen CC; Johnson LE
    Cornell Vet; 1966 Oct; 56(4):623-39. PubMed ID: 6008349
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatotroph and corticotroph pituitary adenoma (double adenoma) in a cat with diabetes mellitus and hyperadrenocorticism.
    Meij BP; van der Vlugt-Meijer RH; van den Ingh TS; Rijnberk A
    J Comp Pathol; 2004; 130(2-3):209-15. PubMed ID: 15003481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanotroph pituitary adenoma in a cat with diabetes mellitus.
    Meij BP; van der Vlugt-Meijer RH; van den Ingh TS; Flik G; Rijnberk A
    Vet Pathol; 2005 Jan; 42(1):92-7. PubMed ID: 15657280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary pars intermedia dysfunction with pituitary gland melanotroph adenoma in a Grevy's zebra (Equus grevyi).
    Takahashi N; Chambers JK; Ota K; Toda K; Yoshimoto Y; Miyajima U; Uchida K
    J Vet Med Sci; 2024 Jan; 86(1):71-76. PubMed ID: 37981318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypophyseal adenocarcinoma in a horse. A case study].
    Martens J; Rosenbruch M
    Tierarztl Prax; 1984; 12(3):354-8. PubMed ID: 6495317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoma of the pars intermedia and hirsutism in a pony.
    Holscher MA; Linnabary RL; Netsky MG; Owen HD
    Vet Med Small Anim Clin; 1978 Sep; 73(9):1197-200. PubMed ID: 252364
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses.
    Heinrichs M; Baumgärtner W; Capen CC
    Vet Pathol; 1990 Nov; 27(6):419-25. PubMed ID: 2177580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.